ASX/AFP (ASX/AFP)

Australian Securities Exchange: ASX/AFP · AUD

A$3.65

-0.07 (-1.9%)· Recorded snapshot

Market cap	393.6M
Revenue (ttm)	212.1M
Net income (ttm)	12.3M
EPS (ttm)	A$0.11
P/E (trailing)	32.7x
P/E (forward)	25.0x
Dividend	A$0.02 (0.66%)
Volume	817
Beta	0.47

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 212.1M
Net income (ttm): 12.3M
EPS (ttm): A$0.11
P/E (trailing): 32.7x
P/E (forward): 25.0x
Market cap: 393.6M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 13:30 UTC

Forward P/E25

P25 n/aP50 n/aP75 n/a

Trailing P/E32.7

P25 n/aP50 n/aP75 n/a

ROE13.7

P25 n/aP50 n/aP75 n/a

ROIC10.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.6%

Nasdaq Composite-2.3%

Dow Jones Industrial Average+1.9%

Russell 2000+1.8%

All ASX/AFP indicators

Market & fundamental data

Available fields

224

Groups with data

Currency

NZD

Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	New Zealand
Country code	AU
Earnings date	2026-11-19
Employees	126
Employees change	9
Employees growth	8.18%
Enterprise value	AUD 427.7M
Exchange	Australian Securities Exchange
Financial currency	NZD
Financial report date	2026-03-31
First seen	2026-05-10
Fiscal year end	March
Founded	1997
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	NZAFTE0001S4
Last earnings date	2026-05-20
Last refreshed	2026-10-29
Market cap	AUD 393.6M
Next earnings date	2026-11-19
Price	AUD 3.65
Price currency	AUD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-29
Symbol	asx/AFP
Website	https://www.aftpharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	39.98x
Average P/E ratio (3Y)	25.11x
Average P/E ratio (5Y)	27.35x
Earnings yield	3.06%
EV/Earnings	34.87x
EV/EBIT	21.91x
EV/EBITDA	20.81x
EV/Sales	2.1x
FCF / EV yield	-1.88%
FCF yield	-2.04%
Forward P/E	25.03x
Graham number	1.4679
Graham upside	-59.78%
Lynch fair value	AUD 1.61
Lynch upside	-55.85%
P/B ratio	4.33x
P/E ratio	32.68x
P/S ratio	1.86x
Price / tangible book value	5.1x
Price/EBITDA ratio	19.01x
Sector forward P/E	33.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	9.6%
EBITDA margin	9.76%
Effective tax rate	35.64%
Gross margin	43.4%
Operating margin	9.6%
Pretax margin	8.59%
Profit margin	5.78%
Profit per employee	AUD 97,331
Profitable quarters	3
Profitable years	7
Revenue per employee	AUD 1.7M
ROA	7.9%
ROA (5Y)	8.81%
ROCE	16.22%
ROE	13.66%
ROE (5Y)	20.25%
ROIC	10.29%
ROIC (5Y)	15.2%
SBC / revenue	0.02%
Tax / revenue	3.06%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	27.27%
EPS growth (Q)	-16.51%
EPS growth (QoQ)	280.2%
EPS growth 3Y	11.27%
EPS growth 5Y	14.63%
EPS growth years	1
Gross profit growth	20.54%
Gross profit growth (Q)	9.63%
Gross profit growth 3Y	14.85%
Gross profit growth 5Y	17.8%
Net income growth	23.14%
Net income growth (Q)	-19.2%
Net income growth (QoQ)	246.63%
Net income growth 3Y	11.4%
Net income growth 5Y	14.17%
Net income growth years	1
Operating income growth	38.51%
Operating income growth (Q)	1.32%
Operating income growth 3Y	7.52%
Operating income growth 5Y	17.95%
Revenue growth	22.44%
Revenue growth (Q)	15.21%
Revenue growth (QoQ)	21.59%
Revenue growth 10Y	14.81%
Revenue growth 3Y	17.59%
Revenue growth 5Y	17.63%
Revenue growth quarters	22
Revenue growth years	13

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -96,577
Depreciation and amortization	AUD 337,451
EBIT	AUD 20.4M
EBITDA	AUD 20.7M
EPS	AUD 0.11
Financing cash flow	AUD 7.3M
Free cash flow	AUD -8M
Free cash flow minus SBC	AUD -8.1M
Gross profit	AUD 92M
Income taxes	AUD 6.5M
Investing cash flow	AUD -8.1M
Net borrowing	AUD 10.5M
Net cash flow	AUD -9M
Net income	AUD 12.3M
Operating cash flow minus SBC	AUD -8M
Operating income	AUD 20.4M
Revenue	AUD 212.1M
Stock-based compensation	AUD 43,293

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.99
Book value per share	AUD 0.88
Debt / EBITDA	2.1
Debt / equity	0.5
Interest coverage	9.83
Long-term assets	AUD 62.2M
Long-term liabilities	AUD 36.9M
Net cash (debt)	AUD -36.5M
Net cash / market cap	-9.28%
Net debt / EBITDA	1.76
Net debt / equity	0.4
Piotroski F-Score	3
Property, plant and equipment	AUD 2.7M
Shareholders' equity	AUD 90.8M
Tangible book value	AUD 77.2M
Tangible book value per share	AUD 0.74
Total assets	AUD 180.7M
Total cash	AUD 8.5M
Total debt	AUD 45M
Total liabilities	AUD 89.9M
WACC	6.41%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.32
Current assets	AUD 118.5M
Current liabilities	AUD 52.9M
Current ratio	2.24
Inventory turnover	2.35
Net working capital	AUD 70.3M
Quick ratio	1.03
Working capital	AUD 68.4M
Working capital turnover	2.88

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend growth	44.15%
Dividend growth years	2
Dividend payment date	2026-07-03
Dividend payment years	4
Dividend payout frequency	Annual
Dividend per share	AUD 0.02
Dividend yield	0.66%
Ex-dividend date	2026-06-18
Last dividend	AUD 0.02
Payout ratio	12.81%
Shareholder yield	0.66%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	25.86%
10Y return CAGR	2.56%
10Y total return	28.8%
150-day SMA	AUD 3.27
1D price change	-1.88%
1M price change	4.89%
1M total return	4.89%
1W price change	0.55%
1W total return	0.55%
1Y price change	39.85%
1Y return CAGR	40.99%
1Y total return	40.96%
20-day SMA	AUD 3.57
200-day SMA	AUD 3.07
3M price change	1.39%
3M total return	1.39%
3Y price change	14.06%
3Y return CAGR	5.19%
3Y total return	16.38%
50-day SMA	AUD 3.67
50-day SMA vs 200-day SMA	50over200
52-week high	AUD 4.13
52-week high date	2026-07-31
52-week low	AUD 2.64
52-week low date	2025-11-03
5Y price change	-6.41%
5Y return CAGR	-0.86%
5Y total return	-4.23%
6M price change	14.42%
6M total return	15.33%
All-time high	AUD 5.25
All-time high date	2020-11-10
All-time low	AUD 1.90
All-time low date	2019-04-24
Average true range (ATR)	AUD 0.06
Average volume	2.3K
Beta (5Y)	0.47
Change from 52-week high	-11.62%
Change from 52-week low	38.26%
Change from all-time high	-30.48%
Change from all-time low	92.11%
Change from open	-1.88%
Day's gap	0%
Dollar volume	AUD 2,982
High price	AUD 3.72
Low price	AUD 3.65
Monthly RSI	58.07
Open price	AUD 3.72
Position in 52-week range	0%
Previous close	AUD 3.72
Price vs 150-day SMA	11.76%
Price vs 20-day SMA	2.16%
Price vs 200-day SMA	18.78%
Price vs 50-day SMA	-0.41%
Relative volume	0.35
RSI	53.37
Sharpe ratio	0.94
Sharpe ratio (3Y)	0.11
Sortino ratio	1.61
Sortino ratio (3Y)	0.28
Volume	817
Weekly RSI	57.45
YTD price change	21.67%
YTD total return	22.64%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	30.4M
Shares change (QoQ)	-9.22%
Shares held by insiders	69.38%
Shares held by institutions	8.05%

Deeper analysis on ASX/AFP

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this ASX/AFP report

Is a complete ASX/AFP research report available?

No complete published report is available for asx/AFP (ASX/AFP) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

393.6M

Revenue (ttm)

212.1M

Net income (ttm)

12.3M

EPS (ttm)

A$0.11

P/E (trailing)

32.7x

P/E (forward)

25.0x

Dividend

A$0.02 (0.66%)

Volume

817

Beta

0.47

Metric

Value

Amount currency

AUD

Country

New Zealand

Country code

Earnings date

2026-11-19

Employees

126

Employees change

Employees growth

8.18%

Enterprise value

AUD 427.7M

Exchange

Australian Securities Exchange

Financial currency

NZD

Financial report date

2026-03-31

First seen

2026-05-10

Fiscal year end

March

Founded

1997

Industry

Drug Manufacturers - Specialty & Generic

Is primary listing

ISIN number

NZAFTE0001S4

Last earnings date

2026-05-20

Last refreshed

2026-10-29

Market cap

AUD 393.6M

Next earnings date

2026-11-19

Price

AUD 3.65

Price currency

AUD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-29

Symbol

asx/AFP

Website

https://www.aftpharm.com

Metric

Value

Average P/E ratio (10Y)

39.98x

Average P/E ratio (3Y)

25.11x

Average P/E ratio (5Y)

27.35x

Earnings yield

3.06%

EV/Earnings

34.87x

EV/EBIT

21.91x

EV/EBITDA

20.81x

EV/Sales

2.1x

FCF / EV yield

-1.88%

FCF yield

-2.04%

Forward P/E

25.03x

Graham number

1.4679

Graham upside

-59.78%

Lynch fair value

AUD 1.61

Lynch upside

-55.85%

P/B ratio

4.33x

P/E ratio

32.68x

P/S ratio

1.86x

Price / tangible book value

5.1x

Price/EBITDA ratio

19.01x

Sector forward P/E

33.91x

Metric

Value

EBIT margin

9.6%

EBITDA margin

9.76%

Effective tax rate

35.64%

Gross margin

43.4%

Operating margin

9.6%

Pretax margin

8.59%

Profit margin

5.78%

Profit per employee

AUD 97,331

Profitable quarters

Profitable years

Revenue per employee

AUD 1.7M

ROA

7.9%

ROA (5Y)

8.81%

ROCE

16.22%

ROE

13.66%

ROE (5Y)

20.25%

ROIC

10.29%

ROIC (5Y)

15.2%

SBC / revenue

0.02%

Tax / revenue

3.06%

Metric

Value

EPS growth

27.27%

EPS growth (Q)

-16.51%

EPS growth (QoQ)

280.2%

EPS growth 3Y

11.27%

EPS growth 5Y

14.63%

EPS growth years

Gross profit growth

20.54%

Gross profit growth (Q)

9.63%

Gross profit growth 3Y

14.85%

Gross profit growth 5Y

17.8%

Net income growth

23.14%

Net income growth (Q)

-19.2%

Net income growth (QoQ)

246.63%

Net income growth 3Y

11.4%

Net income growth 5Y

14.17%

Net income growth years

Operating income growth

38.51%

Operating income growth (Q)

1.32%

Operating income growth 3Y

7.52%

Operating income growth 5Y

17.95%

Revenue growth

22.44%

Revenue growth (Q)

15.21%

Revenue growth (QoQ)

21.59%

Revenue growth 10Y

14.81%

Revenue growth 3Y

17.59%

Revenue growth 5Y

17.63%

Revenue growth quarters

Revenue growth years

Metric

Value

Capital expenditures

AUD -96,577

Depreciation and amortization

AUD 337,451

EBIT

AUD 20.4M

EBITDA

AUD 20.7M

EPS

AUD 0.11

Financing cash flow

AUD 7.3M

Free cash flow

AUD -8M

Free cash flow minus SBC

AUD -8.1M

Gross profit

AUD 92M

Income taxes

AUD 6.5M

Investing cash flow

AUD -8.1M

Net borrowing

AUD 10.5M

Net cash flow

AUD -9M

Net income

AUD 12.3M

Operating cash flow minus SBC

AUD -8M

Operating income

AUD 20.4M

Revenue

AUD 212.1M

Stock-based compensation

AUD 43,293

Metric

Value

Altman Z-Score

3.99

Book value per share

AUD 0.88

Debt / EBITDA

2.1

Debt / equity

0.5

Interest coverage

9.83

Long-term assets

AUD 62.2M

Long-term liabilities

AUD 36.9M

Net cash (debt)

AUD -36.5M

Net cash / market cap

-9.28%

Net debt / EBITDA

1.76

Net debt / equity

0.4

Piotroski F-Score

Property, plant and equipment

AUD 2.7M

Shareholders' equity

AUD 90.8M

Tangible book value

AUD 77.2M

Tangible book value per share

AUD 0.74

Total assets

AUD 180.7M

Total cash

AUD 8.5M

Total debt

AUD 45M

Total liabilities

AUD 89.9M

WACC

6.41%

Metric

Value

Asset turnover

1.32

Current assets

AUD 118.5M

Current liabilities

AUD 52.9M

Current ratio

2.24

Inventory turnover

2.35

Net working capital

AUD 70.3M

Quick ratio

1.03

Working capital

AUD 68.4M

Working capital turnover

2.88

Metric

Value

Dividend growth

44.15%

Dividend growth years

Dividend payment date

2026-07-03

Dividend payment years

Dividend payout frequency

Annual

Dividend per share

AUD 0.02

Dividend yield

0.66%

Ex-dividend date

2026-06-18

Last dividend

AUD 0.02

Payout ratio

12.81%

Shareholder yield

0.66%

Metric

Value

10Y price change

25.86%

10Y return CAGR

2.56%

10Y total return

28.8%

150-day SMA

AUD 3.27

1D price change

-1.88%

1M price change

4.89%

1M total return

4.89%

1W price change

0.55%

1W total return

0.55%

1Y price change

39.85%

1Y return CAGR

40.99%

1Y total return

40.96%

20-day SMA

AUD 3.57

200-day SMA

AUD 3.07

3M price change

1.39%

3M total return

1.39%

3Y price change

14.06%

3Y return CAGR

5.19%

3Y total return

16.38%

50-day SMA

AUD 3.67

50-day SMA vs 200-day SMA

50over200

52-week high

AUD 4.13

52-week high date

2026-07-31

52-week low

AUD 2.64

52-week low date

2025-11-03

5Y price change

-6.41%

5Y return CAGR

-0.86%

5Y total return

-4.23%

6M price change

14.42%

6M total return

15.33%

All-time high

AUD 5.25

All-time high date

2020-11-10

All-time low

AUD 1.90

All-time low date

2019-04-24

Average true range (ATR)

AUD 0.06

Average volume

2.3K

Beta (5Y)

0.47

Change from 52-week high

-11.62%

Change from 52-week low

38.26%

Change from all-time high

-30.48%

Change from all-time low

92.11%

Change from open

-1.88%

Day's gap

Dollar volume

AUD 2,982

High price

AUD 3.72

Low price

AUD 3.65

Monthly RSI

58.07

Open price

AUD 3.72

Position in 52-week range

Previous close

AUD 3.72

Price vs 150-day SMA

11.76%

Price vs 20-day SMA

2.16%

Price vs 200-day SMA

18.78%

Price vs 50-day SMA

-0.41%

Relative volume

0.35

RSI

53.37

Sharpe ratio

0.94

Sharpe ratio (3Y)

0.11

Sortino ratio

1.61

Sortino ratio (3Y)

0.28

Volume

817

Weekly RSI

57.45

YTD price change

21.67%

YTD total return

22.64%

Metric

Value

Float

30.4M

Shares change (QoQ)

-9.22%

Shares held by insiders

69.38%

Shares held by institutions

8.05%

ASX/AFP (ASX/AFP)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/AFP

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/AFP indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/AFP

Frequently asked questions

ASX/AFP (ASX/AFP)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/AFP

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/AFP indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/AFP

Frequently asked questions